Filter Results :

Your search for Biopharmaceutical returned 73 reports

Sort by


Regenerx Biopharmaceuticals Inc. Company Profile- Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

01 May 2016  |  Published by:  OG Analysis
“Regenerx Biopharmaceuticals Inc. Business Profile” is a comprehensive research on the company’s operations across the value chain. The report on Regenerx Biopharmaceuticals Inc. analyzes the company’s key strategies, SWOT analysis, future plans and evaluates its key advantages over its competitors....

$ 200.00

Read More

Keryx Biopharmaceuticals, Inc. (KERX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

15 Apr 2016  |  Published by:  GlobalData
SummaryKeryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company which develops and commercializes innovative therapies for the treatment of renal disease. The company's lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based compound. It has the capacity to ...

$ 250.00

Read More

Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummarySino Biopharmaceutical Limited (Sino) is a pharmaceutical company that develops, manufactures and markets a range of Chinese medicines and chemical medicines. The company manufactures, sells and distributes modernized Chinese medicine products and western medicine products. It provides long t...

$ 300.00

Read More

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryXTL Biopharmaceuticals Ltd. (XTL) is a clinical stage biopharmaceutical company, which focuses on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs. XTL's pipeline products include hCDR1 peptide, recombinant erythropoietin ...

$ 300.00

Read More

Eiger BioPharmaceuticals, Inc. (EIGR) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryEiger BioPharmaceuticals, Inc. (Eiger) formerly Celladon Corporation is a clinical stage biopharmaceutical company that discovers and develops novel drugs for the treatment of orphan diseases. The company's product pipeline portfolio includes lonafarnib, exendin and ubenimex. Eiger's drug can...

$ 300.00

Read More

Navidea Biopharmaceuticals, Inc. (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

15 Apr 2016  |  Published by:  GlobalData
SummaryNavidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. The company by utilizing its Manocept platform develops multiple precision-...

$ 250.00

Read More

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryProvectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The company's products include PV-10 for recurrent melanoma, PV-10 for metastatic liver cancer and PV...

$ 300.00

Read More

Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) - Global Forecasts to 2021

06 Apr 2016  |  Published by:  MarketsandMarkets
The cell lysis market is expected to reach USD 3.84 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.3%. The global cell lysis market is segmented based on product, type of cell, end-users, and regions. The consumables segment is expected to register the highest growth rate in th...

$ 4,650.00

Read More

Opportunity in the Indian Biopharmaceuticals Market - 2016: Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

04 Apr 2016  |  Published by:  Feedback Consulting
This report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices.In depth market scenario includes;- Indian Biopharmaceuticals Market Size- Market share of key players – Top companies- Market size for Vaccines- Market size for Di...

$ 6,000.00
$ 4,200.00
( Save 30% )

Read More

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

04 Apr 2016  |  Published by:  MarketsandMarkets
The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, filtration systems, other products and services. Based on application segment includes b...

$ 4,650.00

Read More

SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016

31 Mar 2016  |  Published by:  Global Markets Direct
Summary ‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the SK Biopharmaceuticals Co., Ltd.’s pharmac...

$ 1,500.00

Read More

Biopharmaceuticals Industry Forecasts - China Focus

18 Mar 2016  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China’s Biopharmaceuticals industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

$ 1,000.00

Read More

Biopharmaceuticals Companies in China

18 Mar 2016  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China’s Biopharmaceuticals industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society an...

$ 1,800.00

Read More

Biopharmaceuticals Markets in China

18 Mar 2016  |  Published by:  Asia Market Info and Dev Co.
China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & expor...

$ 4,000.00

Read More

Innovate Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

18 Mar 2016  |  Published by:  GlobalData
SummaryInnovate Biopharmaceuticals, Inc. (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 i...

$ 250.00

Read More
Total 73 records.